Aigen Investment Management LP Acquires 1,502 Shares of Chemed Co. (NYSE:CHE)

Aigen Investment Management LP grew its position in Chemed Co. (NYSE:CHE) by 300.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,002 shares of the company’s stock after acquiring an additional 1,502 shares during the quarter. Aigen Investment Management LP’s holdings in Chemed were worth $1,061,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in the company. State Street Corp increased its stake in Chemed by 0.8% in the 3rd quarter. State Street Corp now owns 464,354 shares of the company’s stock worth $279,063,000 after acquiring an additional 3,564 shares during the last quarter. Geode Capital Management LLC increased its stake in Chemed by 4.9% in the 3rd quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock worth $201,820,000 after acquiring an additional 15,791 shares during the last quarter. Impax Asset Management Group plc increased its stake in Chemed by 4.7% in the 3rd quarter. Impax Asset Management Group plc now owns 332,757 shares of the company’s stock worth $199,977,000 after acquiring an additional 14,814 shares during the last quarter. Boston Trust Walden Corp increased its stake in Chemed by 10.0% in the 4th quarter. Boston Trust Walden Corp now owns 242,172 shares of the company’s stock worth $128,303,000 after acquiring an additional 22,105 shares during the last quarter. Finally, FMR LLC increased its stake in Chemed by 23.8% in the 3rd quarter. FMR LLC now owns 238,616 shares of the company’s stock worth $143,401,000 after acquiring an additional 45,917 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Insider Transactions at Chemed

In related news, VP Brian C. Judkins bought 145 shares of the company’s stock in a transaction dated Monday, December 30th. The stock was purchased at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the acquisition, the vice president now owns 1,678 shares in the company, valued at $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 3.32% of the company’s stock.

Chemed Stock Performance

Shares of Chemed stock opened at $595.07 on Thursday. The stock has a market cap of $8.96 billion, a price-to-earnings ratio of 30.07, a price-to-earnings-growth ratio of 2.15 and a beta of 0.48. The stock has a 50 day moving average price of $549.47 and a 200-day moving average price of $563.54. Chemed Co. has a one year low of $512.12 and a one year high of $654.62.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. The ex-dividend date is Monday, February 24th. Chemed’s dividend payout ratio (DPR) is 10.05%.

Analysts Set New Price Targets

Separately, StockNews.com downgraded Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, February 27th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.